Luc Bonnefoy - Jun 1, 2023 Form 3 Insider Report for Bausch & Lomb Corp (BLCO)

Role
President,Surgical
Signature
/s/ Debra E. Levin, attorney-in-fact
Stock symbol
BLCO
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
3
Date filed
6/12/2023, 04:05 PM
Next filing
Jun 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BLCO Common Shares, No Par Value 39.4K Jun 1, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BLCO Non-Qualified Stock Options (right to purchase) Jun 1, 2023 Common Shares 84K $18.00 Direct F3, F5
holding BLCO Non-Qualified Stock Options (right to purchase) Jun 1, 2023 Common Shares 19.7K $17.96 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects (i) an award of 21,222 restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") granted on May 5, 2022 which is generally scheduled to vest 50% on the second anniversary of the grant date and 50% on the third anniversary of the date of grant or, if later, the earlier of Bausch + Lomb Corporation's (the "Issuer") full separation from Bausch Health Companies, Inc. ("BHC") or a change in control of the Issuer, (ii) an award of 12,000 RSUs under the Plan granted on August 2, 2022 which is generally scheduled to vest 1/3rd on each of the first three anniversaries of the date of grant and (iii) an award of 6,146 RSUs under the Plan granted on March 1, 2023 which is generally scheduled to vest 1/3rd on each of the first three anniversaries of the date of grant, in each case subject to the terms of the Plan and the applicable award agreement and continued employment through the applicable vesting date.
F2 (continued from footnote 1) Vested RSUs are settled in common shares, no par value ("Common Shares"), of the Issuer.
F3 Reflects an award of stock options to purchase Common Shares granted under the Plan on May 5, 2022. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date or, if later, upon the full separation from BHC or a change in control of the Issuer, subject to the terms of the Plan and the applicable award agreement and continued employment through the applicable vesting date.
F4 Reflects an award of stock options to purchase Common Shares granted under the Plan on March 1, 2023. The stock options are generally scheduled to vest and become exercisable in equal installments on each of the first three anniversaries of the grant date, subject to the terms of the applicable award agreement.
F5 The stock options will expire on the tenth anniversary of the grant date.

Remarks:

Exhibit List: 24.1 - Power of Attorney